Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2. - Li X; Wang J; Li S; Fang J; Hao Y; Xu C; Shu Y; Shu H; Chen J; Lu N; Zhu X; Wang K; et al. (Cellular oncology (Dordrecht, Netherlands), 2025)